Skip to main content
Fig. 1 | Cardiovascular Diabetology

Fig. 1

From: Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study

Fig. 1

Flow chart for the inclusion of study patients. Patients with hypertension and type 2 diabetes mellitus who were hospitalized due to acute ischemic stroke were enrolled after the relevant exclusion criteria were applied. The patients were further divided into pioglitazone and non-pioglitazone groups according to their prescribed oral anti-diabetic drugs. ARB angiotensin receptor blocker

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840